Skip Navigation

OU College of Medicine Student Earns Pathology Honor

NEWS
Michael Lee, student, OU College of Medicine, The University of Oklahoma. Medical Student 1 of 8 Selected As Kinney Scholar.

OU College of Medicine Student Earns Pathology Honor


By

Date

June 3, 2025

OKLAHOMA CITY – University of Oklahoma College of Medicine student Michael Lee is one of eight medical students nationwide to be named a Society of ’67 Thomas D. Kinney Scholar, a program of the Association for Academic Pathology (AAPath).

Lee, a third-year medical student, said the Kinney Scholar program will enable him to deepen his understanding of the critical role of pathology in health care delivery, research and education. He will attend the 2025 AAPath annual meeting in Colorado, where he will gain insight from national leaders in academic pathology.

“It’s a great honor to be selected,” Lee said. “This is a valuable and unique opportunity to attend the AAPath annual meeting and explore academic pathology, the challenges facing the field, and what my role might be in the future. It will be a great learning experience to connect with others in the field.”

Lee is the president of the OU College of Medicine Pathology Interest Group. He has long been interested in the role of pathology in medicine, both for its grounding in basic science and its essential function in patient care.

“During my preclinical education, I realized that pathology is a specialty that is deeply connected to the mechanisms of disease,” he said. “Now, during my clinical training, I see pathology in every part of the hospital. Pathology provides objective information and is a pivotal and guiding force in the kind of treatment a patient receives and their outcomes.”

Lee plans to eventually practice pathology in academia, where he can pursue two of his passions, research and education. He is particularly drawn to dermatopathology, a field that focuses on the diagnosis of skin diseases, and hematopathology, which centers on diseases affecting the blood.

“But I’m definitely keeping an open mind,” he said. “There are pathology specialties for pretty much every organ system, so there are a lot to choose from.”

The Society of ’67 Thomas D. Kinney Scholars Program was named in 2021 to honor Dr. Thomas D. Kinney, one of the founders of AAPath and a leader in pathology education and training.

About the University of Oklahoma

Founded in 1890, the University of Oklahoma is a public research university with campuses in Norman, Oklahoma City and Tulsa. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. In Oklahoma City, OU Health Sciences is one of the nation’s few academic health centers with seven health profession colleges located on the same campus. OU Health Sciences serves approximately 4,000 students in more than 70 undergraduate and graduate degree programs spanning Oklahoma City and Tulsa and is the leading research institution in Oklahoma. For more information about OU Health Sciences, visit www.ouhsc.edu.


Recent News

Campus & Community
April 27, 2026

175 OU Students Present Research at 38th Annual Undergraduate Research Day

The University of Oklahoma Honors College hosted its 38th annual Undergraduate Research Day on April 16 in the Thurman J. White Forum Building. Over 300 people attended, and 175 students presented their posters and projects to visitors, faculty members, judges and peers.


Impact
April 24, 2026

Where Practice Meets Leadership: OU and CCOSA Introduce Collaborative Ed.D.

The Collaborative Doctor of Education (Ed.D.) in Educational Leadership offers emerging leaders across Oklahoma’s PK–12 public education system a doctoral experience designed to be as relevant as it is rigorous.


Research
April 23, 2026

Genetic Study Finds New Pathways Involved in Cardiometabolic Disease

A study published today in PLOS Medicine has identified two new genetic pathways that contribute to cardiometabolic disease, which includes heart disease, obesity and diabetes. The research, led by Dharambir Sanghera, Ph.D., of the University of Oklahoma, represents a step toward targeting the diseases more precisely.